These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5207895)

  • 21. Editorial: Cannabis--harmless or dangerous?
    Ceylon Med J; 1971 Jun; 16(2):67-8. PubMed ID: 5163548
    [No Abstract]   [Full Text] [Related]  

  • 22. Substance abuse and major trauma in Johannesburg.
    Bowley DM; Rein P; Cherry R; Vellema J; Snyman T; Boffard KD
    S Afr J Surg; 2004 Feb; 42(1):7-10. PubMed ID: 15181707
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Join the war on drug abuse. 2.
    Alexander RE
    Dent Econ; 1969 Mar; 59(3):34-6 passim. PubMed ID: 5250651
    [No Abstract]   [Full Text] [Related]  

  • 24. Substance abuse--concerns in dentistry: an overview.
    van der Bijl P
    SADJ; 2003 Nov; 58(10):382-5. PubMed ID: 15042883
    [No Abstract]   [Full Text] [Related]  

  • 25. [Narcotics abuse in teenagers].
    Lloyd D
    Sykepleien; 1971 May; 58(10):338-41. PubMed ID: 5208999
    [No Abstract]   [Full Text] [Related]  

  • 26. [Related, induced and associated psychiatric disorders to cannabis].
    Laqueille X
    Rev Prat; 2005 Jan; 55(1):30-4. PubMed ID: 15801394
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cannabis and cocaine: a lethal cocktail triggering coronary sudden death.
    Montisci M; Thiene G; Ferrara SD; Basso C
    Cardiovasc Pathol; 2008; 17(5):344-6. PubMed ID: 18402793
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cognitive deficits and cognitive normality in recreational cannabis and Ecstasy/MDMA users.
    Parrott A
    Hum Psychopharmacol; 2003 Mar; 18(2):89-90. PubMed ID: 12590401
    [No Abstract]   [Full Text] [Related]  

  • 29. [Psychopathological syndromes following use of marihuana. Observations from Morocco].
    Vierth G
    Munch Med Wochenschr; 1967 Mar; 109(10):522-6. PubMed ID: 5631095
    [No Abstract]   [Full Text] [Related]  

  • 30. Impact of cannabis use on brain function in adolescents.
    Jacobsen LK; Mencl WE; Westerveld M; Pugh KR
    Ann N Y Acad Sci; 2004 Jun; 1021():384-90. PubMed ID: 15251914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adequate antipsychotic treatment normalizes serum nerve growth factor concentrations in schizophrenia with and without cannabis or additional substance abuse.
    Jockers-Scherübl MC; Rentzsch J; Danker-Hopfe H; Radzei N; Schürer F; Bahri S; Hellweg R
    Neurosci Lett; 2006 Jun; 400(3):262-6. PubMed ID: 16540246
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Acute and chronic cognitive disorders caused by cannabis use].
    Karila L; Vignau J; Alter C; Reynaud M
    Rev Prat; 2005 Jan; 55(1):23-6; discussion 27-9. PubMed ID: 15801393
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cocaine treatment admissions at three sentinel sites in South Africa (1997-2006): findings and implications for policy, practice and research.
    Parry CD; Plüddemann A; Myers BJ
    Subst Abuse Treat Prev Policy; 2007 Dec; 2():37. PubMed ID: 18163901
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hashish and the development of addiction in a 17 year-old girl].
    Petri H
    Prax Kinderpsychol Kinderpsychiatr; 1970 Oct; 19(7):242-5. PubMed ID: 5511619
    [No Abstract]   [Full Text] [Related]  

  • 35. Adverse reaction to the use of marijuana.
    Marten GW
    J Tenn Med Assoc; 1969 Jul; 62(7):627-30. PubMed ID: 5795951
    [No Abstract]   [Full Text] [Related]  

  • 36. History, culture and subjective experience: an exploration of the social bases of drug-induced experiences.
    Becker HS
    J Health Soc Behav; 1967 Sep; 8(3):163-76. PubMed ID: 6073200
    [No Abstract]   [Full Text] [Related]  

  • 37. Recurrent LSD experience (flashbacks) triggered by marihuana.
    Favazza AR; Domino EF
    Univ Mich Med Cent J; 1969; 35(4):214-6. PubMed ID: 5377289
    [No Abstract]   [Full Text] [Related]  

  • 38. Heavy cannabis users seeking treatment- prevalence of psychiatric disorders.
    Arendt M; Munk-Jørgensen P
    Soc Psychiatry Psychiatr Epidemiol; 2004 Feb; 39(2):97-105. PubMed ID: 15052390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are specific dependence criteria necessary for different substances: how can research on cannabis inform this issue?
    Budney AJ
    Addiction; 2006 Sep; 101 Suppl 1():125-33. PubMed ID: 16930169
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Induced psychiatric and somatic disorders to cannabis].
    Laqueille X; Launay C; Kanit M
    Ann Pharm Fr; 2008 Aug; 66(4):245-54. PubMed ID: 18847572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.